Letter: Loculation as a contraindication to intracavitary 32P-chromic phosphate therapy.
D000005:Abdomen; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D009366:Neoplasm Seeding / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010190:Pancreatic Neoplasms / Q000532:radiotherapy; D010529:Peritoneal Cavity; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D011877:Radionuclide Imaging
D010761:Phosphorus Radioisotopes